AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS

(19)

(11)

EP 3 157 577 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	23.12.2020 Bulletin 2020/52

(45)	Mention of the grant of the patent:
	28.10.2020 Bulletin 2020/44

(21)	Application number: 15809093.6

(22)	Date of filing: 17.06.2015

(51)

International Patent Classification (IPC):

C07B 59/00^(2006.01)
A61K 51/10^(2006.01)

A61P 35/00^(2006.01)

(86)	International application number:
	PCT/SE2015/050714

(87)	International publication number:
	WO 2015/195042 (23.12.2015 Gazette 2015/51)

(54)

AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS

AUTOMATISCHE VERFAHRENSPLATTFORM ZUR HERSTELLUNG VON ASTATINE-211[AT-211]-RADIOPHARMAZEUTIKA

PLATEFORME DE PROCESSUS AUTOMATIQUE POUR LA PRODUCTION DE PRODUITS RADIOPHARMACEUTIQUES MARQUÉS À L'ASTATINE-211 [AT-211]

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

18.06.2014 US 201462013678 P

(43)	Date of publication of application:
	26.04.2017 Bulletin 2017/17

(73)	Proprietor: Alpha Therapy Solutions AB
	412 92 Göteborg (SE)

(72)	Inventors:
	Lindegren, Sture 434 97 Kungsbacka (SE) Aneheim, Emma 415 71 Göteborg (SE)

(74)	Representative: Bergquist, Kjell Gunnar
	Westpatent AB Almekärrsvägen 11 443 39 Lerum 443 39 Lerum (SE)

(56)

References cited: :

WO-A1-91/09626
US-A- 4 826 672

US-A- 4 681 727

ANEHEIM, EMMA ET AL.: 'Automated astatination of biomolecules- a stepping stone towards multicenter clinical trials' SCIENTIFIC REPORTS vol. 5, 2015, page 12 025, XP055245286
ANEHEIM, EMMA ET AL.: 'Astatine-21 labeling: a study towards automatic production of astatinated antibodies' JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY vol. 303, no. 1, 2015, pages 979 - 983, XP035418258

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).